Cargando…
Gender, hormone therapy, and HIV: what should cardiologists know?
Transgender individuals represent the fastest growing minority in the United States and are disproportionately affected by HIV. Hormone therapy is the most common treatment for gender dysphoria in transgender individuals. As HIV is an independent risk factor for coronary artery disease, it is critic...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470229/ https://www.ncbi.nlm.nih.gov/pubmed/30671882 http://dx.doi.org/10.1007/s12471-019-1233-6 |
_version_ | 1783411754749919232 |
---|---|
author | Martinez, C. A. Rikhi, R. R. |
author_facet | Martinez, C. A. Rikhi, R. R. |
author_sort | Martinez, C. A. |
collection | PubMed |
description | Transgender individuals represent the fastest growing minority in the United States and are disproportionately affected by HIV. Hormone therapy is the most common treatment for gender dysphoria in transgender individuals. As HIV is an independent risk factor for coronary artery disease, it is critical to further research the influence masculinising and feminising hormone therapies have on cardiovascular disease. There is a clinical need for evidence-based guidelines for cardiologists to follow to effectively care for and treat transgender patients. For this to be done, the interplay between HIV, hormone therapy, and cardiovascular disease must be better understood through collaboration between researchers and clinicians to achieve maximum benefit from recent advancements. |
format | Online Article Text |
id | pubmed-6470229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Bohn Stafleu van Loghum |
record_format | MEDLINE/PubMed |
spelling | pubmed-64702292019-05-03 Gender, hormone therapy, and HIV: what should cardiologists know? Martinez, C. A. Rikhi, R. R. Neth Heart J Point of View Transgender individuals represent the fastest growing minority in the United States and are disproportionately affected by HIV. Hormone therapy is the most common treatment for gender dysphoria in transgender individuals. As HIV is an independent risk factor for coronary artery disease, it is critical to further research the influence masculinising and feminising hormone therapies have on cardiovascular disease. There is a clinical need for evidence-based guidelines for cardiologists to follow to effectively care for and treat transgender patients. For this to be done, the interplay between HIV, hormone therapy, and cardiovascular disease must be better understood through collaboration between researchers and clinicians to achieve maximum benefit from recent advancements. Bohn Stafleu van Loghum 2019-01-22 2019-05 /pmc/articles/PMC6470229/ /pubmed/30671882 http://dx.doi.org/10.1007/s12471-019-1233-6 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Point of View Martinez, C. A. Rikhi, R. R. Gender, hormone therapy, and HIV: what should cardiologists know? |
title | Gender, hormone therapy, and HIV: what should cardiologists know? |
title_full | Gender, hormone therapy, and HIV: what should cardiologists know? |
title_fullStr | Gender, hormone therapy, and HIV: what should cardiologists know? |
title_full_unstemmed | Gender, hormone therapy, and HIV: what should cardiologists know? |
title_short | Gender, hormone therapy, and HIV: what should cardiologists know? |
title_sort | gender, hormone therapy, and hiv: what should cardiologists know? |
topic | Point of View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470229/ https://www.ncbi.nlm.nih.gov/pubmed/30671882 http://dx.doi.org/10.1007/s12471-019-1233-6 |
work_keys_str_mv | AT martinezca genderhormonetherapyandhivwhatshouldcardiologistsknow AT rikhirr genderhormonetherapyandhivwhatshouldcardiologistsknow |